NET LOSS PER SHARE - Anti-dilutive (Details) - shares |
9 Months Ended | |
|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Warrants | ||
| NET LOSS PER SHARE | ||
| Anti-dilutive excluded from the calculation of diluted net loss per common stock | 137,790 | 159,870 |
| Options | ||
| NET LOSS PER SHARE | ||
| Anti-dilutive excluded from the calculation of diluted net loss per common stock | 348,281 | 348,281 |
| Unvested RSAs | ||
| NET LOSS PER SHARE | ||
| Anti-dilutive excluded from the calculation of diluted net loss per common stock | 3,057,634 | 2,434,123 |
| Unvested RSAs | Mr. Ron Bentsur, Dr. Enrique Poradosu, and Mr. Shay Shemesh | ||
| NET LOSS PER SHARE | ||
| Anti-dilutive excluded from the calculation of diluted net loss per common stock | 193,557 | 193,557 |